Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuko Nagata
Institution:
Fukuoka Higashi Medical Center
Observed institutions:
Fukuoka Hospital,
Fukuoka Higashi Medical Center,
National Hospital Organization
ORCID:
0000-0002-6667-1996
Observed ORCID:
0000-0002-6667-1996
OpenAlex ID:
A5055136969
Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study
2023
·
Airi Fujimoto
, Yoshimichi Koutake
, et al.
·
Cancer Immunology Immunotherapy
·
17
PDF
Successful switch to cisplatin-based chemotherapy in a patient with lung cancer who developed a carboplatin-induced hypersensitivity reaction
2024
·
Yuko Nagata
, Gouji Toyokawa
, et al.
·
Journal of Oncology Pharmacy Practice
·
3
Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study
2024
·
Airi Fujimoto
, Yoshimichi Koutake
, et al.
·
Cancer Immunology Immunotherapy
·
1
PDF
Preventive Effects of SGLT2 Inhibitors on Cisplatin-Induced Nephrotoxicity in Patients with Solid Tumors and Diabetes: A Multicenter, Retrospective Cohort Study
2026
·
Masaya Kanda
, Toshinobu Hayashi
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
4
Citation count:
21
H-index:
2
I10-index:
1
Year
Topic
Type